Post-Operative Use of FS2 to Mitigate Scarring in Burn Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Post-Operative Use of FS2 to Mitigate Scarring in Burn Patients — Stella

Recruiting

Back to Burn Scar trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

Canada

University of Alberta, Division of Plastic Surgery, Edmonton, Alberta

Centre for Burn Research - Hamilton Health Sciences, Hamilton, Ontario

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Birch BioMed Inc

Collaborators

Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Enrollment target

~70 participants

Started

December 2025

Primary completion

October 2026

Age range

18 Years – 60 Years

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov